SMFRW News and Press, Sema4 Holdings Corp. Warrant From 06/13/22

The following slide deck was published by Sema4 Holdings Corp. in conjunction with this event. For further details see: Sema4 Holdings (SMFR) Investor Presentation - Slideshow

SIOUX FALLS, S.D. and STAMFORD, Conn., June 01, 2022 (GLOBE NEWSWIRE) -- Avera Health , an integrated regional health care system that serves 300 locations across the Upper Midwest, and Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today...

STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate at the following investor conferences: Conference: Jefferies Healthcare Conf...

The following slide deck was published by Sema4 Holdings Corp. in conjunction with their 2022 Q1 earnings call. For further details see: Sema4 Holdings Corp. 2022 Q1 - Results - Earnings Call Presentation

Sema4 Holdings Corp. (SMFR) Q1 2022 Earnings Conference Call May 13, 2022 04:30 p.m. ET Company Representatives Katherine Stueland - Chief Executive Officer Eric Schadt - Founder, President and Chief R&D Officer Isaac Ro - Chief Financial Officer Joel Kaufman - Vice President of Finance a...

Total revenue of $53.9 million 1,300 basis points of sequential adjusted gross margin improvement Reaffirming full year 2022 pro forma revenue target New operating model and focus on efficiencies to reduce 2022 cash burn by an estimated $50 million, extending cas...

STAMFORD, Conn., May 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that, effective as of May 2, 2022, the compensation committee of Sema4’s board of directors granted newly-hired employees ...

Acquisition creates an AI-driven advanced health intelligence company, now leveraging one of the largest genomic testing platforms in the U.S. Katherine Stueland, former President and CEO of GeneDx, joins Sema4 as CEO and will serve on Board of Directors Eric Schadt, fou...

STAMFORD, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced it will release financial results for the first quarter of 2022 after the market close on Thursday, May 12, 2022. On the same d...

STAMFORD, Conn., April 06, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that its health intelligence platform, Centrellis ® , has earned Certified status for information security by the Heal...